Report cover image

India Community Acquired Pneumonia Drugs Market - Industry Trends and Forecast to 2031

Publisher Data Bridge Market Research
Published Feb 01, 2024
Length 123 Pages
SKU # DAABD18636681

Description

India Community Acquired Pneumonia Drugs Market - Industry Trends and Forecast to 2031


India community acquired pneumonia drugs market is expected to reach USD 162.51 million by 2031, from 92.72 million in 2023 growing at the CAGR of 7.5% in the forecast period of 2024 to 2031.

Market Segmentation

India Community Acquired Pneumonia Drugs Market, By Product (Macrolides, B-Lactam Antibiotics, Quinolones, Tetracycline, Carbapenem, Glycopeptide Antibiotics, Pleuromutilin, and Others), Route of Administration (Oral and Intravenous), Dosage (Tablet and Solution), Product Type (Generics and Branded), Mode of Purchase (Prescription and OTC), Type (Bacterial, Virus, and Fungi), Population Type (Children, Geriatrics, and Adults), End User (Hospitals, Specialty Clinics, Homecare, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others), Country (India) - Industry Trends and Forecast to 2031

Overview of India Community Acquired Pneumonia Drugs Market Dynamics

Driver
• Rising prevalence and burden of pneumonia

Restraint
• Affordability and price sensitivity associated with the drugs

Opportunity
• Technology driven solutions and innovation

Market Players

Some of the key market players operating in the India community acquired pneumonia drugs market are listed below:
• Pfizer Inc.
• Cipla Inc.
• AstraZeneca
• Abbott
• Teva Pharmaceutical Industries Ltd.
• Novartis AG
• FRESENIUS KABI
• Baxter
• Aurobindo Pharma USA

Table of Contents

123 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The India Community Acquired Pneumonia Drugs Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Product Segment Lifeline Curve
2.8 Market End User Coverage Grid
2.9 Dbmr Market Position Grid
2.10 Vendor Share Analysis
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestal Analysis
4.2 Porters Five Forces
5 Regulations
6 Market Overview
6.1 Drivers
6.1.1 Rising Prevalence Of Pneumonia
6.1.2 Growing Antibiotic Resistance Pathogens Drugs
6.1.3 Increasing Healthcare Awareness And Expenditure
6.1.4 Growing Demand For Generic And Locally Produced Drugs
6.2 Restraints
6.2.1 Affordability And Price Sensitivity Associated With The Drugs
6.2.2 Unequal Distribution Of Healthcare Resources In Different Locality
6.2.3 Pipeline Of New Antibiotic Development
6.3 Oppurtunities
6.3.1 Technology-driven Solutions And Innovation
6.3.2 Focus On Affordability And Generics Of The Pneumonia Drugs
6.3.3 Focus On Leveraging Telemedicine And Specific Aged Patient
6.4 Challenges
6.4.1 Limited Healthcare Infrastructure And Access
6.4.2 Antibiotic Resistance And Counterfeiting In Pharmaceutical Drugs
7 India Community Acquired Pneumonia Drugs Market, By Product
7.1 Overview
7.2 Macrolides
7.2.1 Azithromycin
7.2.2 Erythromycin
7.2.3 Clarithromycin
7.2.4 Others
7.3 B-lactam Antibiotics
7.3.1 Cephalosporin
7.3.1.1 Third Generation Cephalosporin
7.3.1.2 Second Generation Cephalosporin
7.3.1.3 Fourth Generation Cephalosporin
7.3.1.4 First Generation Cephalosporin
7.3.2 Amoxicillin And Clavulanate Potassium
7.3.3 Piperacillin And Tazobactam
7.3.4 Ampicillin And Sulbactam
7.3.5 Others
7.4 Quinolones
7.4.1 Moxifloxacin
7.4.2 Levofloxacin
7.4.3 Gemifloxacin
7.4.4 Gatifloxacin
7.4.5 Ciprofloxacin
7.4.6 Delafloxacin
7.4.7 Others
7.5 Tetracycline
7.5.1 Doxycycline
7.5.2 Omadacycline
7.5.3 Others
7.6 Carbapenem
7.6.1 Imipenem
7.6.2 Meropenem
7.6.3 Ertapenem
7.7 Glycopeptide Antibiotics
7.7.1 Vancomycin
7.7.2 Teicoplanin
7.7.3 Others
7.8 Pleuromutilin
7.9 Others
8 India Community Acquired Pneumonia Drugs Market, By Route Of Administration
8.1 Overview
8.2 Oral
8.3 Intravenous
9 India Community Acquired Pneumonia Drugs Market, By Dosage
9.1 Overview
9.2 Tablet
9.3 Solution
10 India Community Acquired Pneumonia Drugs Market, By Product Type
10.1 Overview
10.2 Generics
10.3 Branded
11 India Community Acquired Pneumonia Drugs Market, By Mode Of Purchase
11.1 Overview
11.2 Prescription
11.3 Otc
12 India Community Acquired Pneumonia Drugs Market, By Type
12.1 Overview
12.2 Bacterial
12.3 Virus
12.4 Fungi
13 India Community Acquired Pneumonia Drugs Market, By Population Type
13.1 Overview
13.2 Children
13.3 Geriatrics
13.4 Adults
14 India Community Acquired Pneumonia Drugs Market, By End User
14.1 Overview
14.2 Hospitals
14.3 Specialty Clinics
14.4 Home Care
14.5 Others
15 India Community Acquired Pneumonia Drugs Market, By Distribution Channel
15.1 Overview
15.2 Hospital Pharmacy
15.3 Retail Pharmacy
15.4 Online Pharmacy
15.5 Others
16 India Community Acquired Pneumonia Drugs Market, Company Landscape
16.1 Company Share Analysis: India
17 Swot Analysis
18 Company Profiles
18.1 Pfizer Inc.
18.1.1 Company Snapshot
18.1.2 Revenue Analysis
18.1.3 Product Portfolio
18.1.4 Recent Development
18.2 Cipla Inc.
18.2.1 Company Snapshot
18.2.2 Revenue Analysis
18.2.3 Product Portfolio
18.2.4 Recent Development
18.3 Astrazeneca
18.3.1 Company Snapshot
18.3.2 Revenue Analysis
18.3.3 Product Portfolio
18.3.4 Recent Development
18.4 Abbott
18.4.1 Company Snapshot
18.4.2 Revenue Analysis
18.4.3 Product Portfolio
18.4.4 Recent Development
18.5 Teva Pharmaceutical Industries Ltd.
18.5.1 Company Snapshot
18.5.2 Revenue Analysis
18.5.3 Product Portfolio
18.5.4 Recent Developments
18.6 Aurobindo Pharma Usa
18.6.1 Company Snapshot
18.6.2 Revenue Analysis
18.6.3 Product Portfolio
18.6.4 Recent Development
18.7 Baxter
18.7.1 Company Snapshot
18.7.2 Revenue Analysis
18.7.3 Product Portfolio
18.7.4 Recent Development
18.8 Fresenius Kabi
18.8.1 Company Snapshot
18.8.2 Revenue Analysis
18.8.3 Product Portfolio
18.8.4 Recent Development
18.9 Novartis Ag
18.9.1 Company Snapshot
18.9.2 Revenue Analysis
18.9.3 Product Portfolio
18.9.4 Recent Development
19 Questionnaire
20 Related Reports
List Of Tables
Table 1 India Community Acquired Pneumonia Drugs Market, By Product, 2022-2031 (Usd Million)
Table 2 India Macrolides In Community Acquired Pneumonia Drugs Market, By Type, 2022-2031 (Usd Million)
Table 3 India B-lactam Antibiotics In Community Acquired Pneumonia Drugs Market, By Type, 2022-2031 (Usd Million)
Table 4 India Cephalosporin In Community Acquired Pneumonia Drugs Market, By Type, 2022-2031 (Usd Million)
Table 5 India Quinolones In Community Acquired Pneumonia Drugs Market, By Type, 2022-2031 (Usd Million)
Table 6 India Tetracycline In Community Acquired Pneumonia Drugs Market, By Type, 2022-2031 (Usd Million)
Table 7 India Carbapenem In Community Acquired Pneumonia Drugs Market, By Type, 2022-2031 (Usd Million)
Table 8 India Glycopeptide Antibiotics In Community Acquired Pneumonia Drugs Market, By Type, 2022-2031 (Usd Million)
Table 9 India Community Acquired Pneumonia Drugs Market, By Route Of Administration, 2022-2031 (Usd Million)
Table 10 India Community Acquired Pneumonia Drugs Market, By Dosage, 2022-2031 (Usd Million)
Table 11 India Community Acquired Pneumonia Drugs Market, By Product Type, 2022-2031 (Usd Million)
Table 12 India Community Acquired Pneumonia Drugs Market, By Mode Of Purchase 2022-2031 (Usd Million)
Table 13 India Community Acquired Pneumonia Drugs Market, By Type, 2022-2031 (Usd Million)
Table 14 India Community Acquired Pneumonia Drugs Market, By Population Type, 2022-2031 (Usd Million)
Table 15 India Community Acquired Pneumonia Drugs Market, By End User, 2022-2031 (Usd Million)
Table 16 India Community Acquired Pneumonia Drugs Market, By Distribution Channel, 2022-2031 (Usd Million)
List Of Figures
Figure 1 India Community Acquired Pneumonia Drugs Market: Segmentation
Figure 2 India Community Acquired Pneumonia Drugs Market: Data Triangulation
Figure 3 India Community Acquired Pneumonia Drugs Market: Droc Analysis
Figure 4 India Community Acquired Pneumonia Drugs Market: Countrywise Market Analysis
Figure 5 India Community Acquired Pneumonia Drugs Market: Company Research Analysis
Figure 6 India Community Acquired Pneumonia Drugs Market: Interview Demographics
Figure 7 India Community Acquired Pneumonia Drugs Market: Market End User Coverage Grid
Figure 8 India Community Acquired Pneumonia Drugs Market: Dbmr Market Position Grid
Figure 9 India Community Acquired Pneumonia Drugs Market: Vendor Share Analysis
Figure 10 India Community Acquired Pneumonia Drugs Market: Segmentation
Figure 11 Rising Prevalence Of Pneumonia Is Driving The Growth Of The India Community Acquired Pneumonia Drugs Market From 2024 To 2034
Figure 12 Macrolides Segment Is Expected To Account For The Largest Share Of The India Community Acquired Pneumonia Drugs Market In 2024 To 2031
Figure 13 Drivers, Restraints, Opportunities, And Challenges Of Global Rapid Diagnostic Tests (Rtd) Market
Figure 14 India Community Acquired Pneumonia Drugs Market: By Product, 2023
Figure 15 India Community Acquired Pneumonia Drugs Market: By Product, 2024-2031 (Usd Million)
Figure 16 India Community Acquired Pneumonia Drugs Market: By Product, Cagr (2024-2031)
Figure 17 India Community Acquired Pneumonia Drugs Market: By Product, Lifeline Curve
Figure 18 India Community Acquired Pneumonia Drugs Market: By Route Of Administration, 2023
Figure 19 India Community Acquired Pneumonia Drugs Market: By Route Of Administration, 2024-2031 (Usd Million)
Figure 20 India Community Acquired Pneumonia Drugs Market: By Route Of Administration, Cagr (2024-2031)
Figure 21 India Community Acquired Pneumonia Drugs Market: By Route Of Administration, Lifeline Curve
Figure 22 India Community Acquired Pneumonia Drugs Market: By Dosage, 2023
Figure 23 India Community Acquired Pneumonia Drugs Market: By Dosage, 2024-2031 (Usd Million)
Figure 24 India Community Acquired Pneumonia Drugs Market: By Dosage, Cagr (2024-2031)
Figure 25 India Community Acquired Pneumonia Drugs Market: By Dosage, Lifeline Curve
Figure 26 India Community Acquired Pneumonia Drugs Market: By Product Type, 2023
Figure 27 India Community Acquired Pneumonia Drugs Market: By Product Type, 2024-2031 (Usd Million)
Figure 28 India Community Acquired Pneumonia Drugs Market: By Product Type, Cagr (2024-2031)
Figure 29 India Community Acquired Pneumonia Drugs Market: By Product Type, Lifeline Curve
Figure 30 India Community Acquired Pneumonia Drugs Market: By Mode Of Purchase, 2023
Figure 31 India Community Acquired Pneumonia Drugs Market: By Mode Of Purchase, 2024-2031 (Usd Million)
Figure 32 India Community Acquired Pneumonia Drugs Market: By Mode Of Purchase, Cagr (2024-2031)
Figure 33 India Community Acquired Pneumonia Drugs Market: By Mode Of Purchase, Lifeline Curve
Figure 34 India Community Acquired Pneumonia Drugs Market: By Type, 2023
Figure 35 India Community Acquired Pneumonia Drugs Market: By Type, 2024-2031 (Usd Million)
Figure 36 India Community Acquired Pneumonia Drugs Market: By Type, Cagr (2024-2031)
Figure 37 India Community Acquired Pneumonia Drugs Market: By Type, Lifeline Curve
Figure 38 India Community Acquired Pneumonia Drugs Market: By Population Type, 2023
Figure 39 India Community Acquired Pneumonia Drugs Market: By Population Type, 2024-2031 (Usd Million)
Figure 40 India Community Acquired Pneumonia Drugs Market: By Population Type, Cagr (2024-2031)
Figure 41 India Community Acquired Pneumonia Drugs Market: By Population Type, Lifeline Curve
Figure 42 India Community Acquired Pneumonia Drugs Market: By End User, 2023
Figure 43 India Community Acquired Pneumonia Drugs Market: By End User, 2024-2031 (Usd Million)
Figure 44 India Community Acquired Pneumonia Drugs Market: By End User, Cagr (2024-2031)
Figure 45 India Community Acquired Pneumonia Drugs Market: By End User, Lifeline Curve
Figure 46 India Community Acquired Pneumonia Drugs Market: By Distribution Channel, 2023
Figure 47 India Community Acquired Pneumonia Drugs Market: By Distribution Channel, 2024-2031 (Usd Million)
Figure 48 India Community Acquired Pneumonia Drugs Market: By Distribution Channel, Cagr (2024-2031)
Figure 49 India Community Acquired Pneumonia Drugs Market: By Distribution Channel, Lifeline Curve
Figure 50 India Community Acquired Pneumonia Drugs Market: Company Share 2023 (%)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us